Business

Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders and Thanks Director Dr. John Mull

Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders an...

articleCipher Pharmaceuticals Inc.June 22, 20224/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-announces-results-of-annual-and-special-meeting-of-shareholders-and-thanks-director-dr-john-mull
Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders and Thanks Director Dr. John Mull

About this update from Cipher Pharmaceuticals Inc.

[{"type":"text","content":"\n \n \n \n Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders and Thanks Director Dr. John Mull\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen2{\nPADDING-RIGHT:0.17em; PADDING-LEFT:0.17em; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BORDER-TOP:black 1pt; BORDER-RIGHT:black 1pt; BORDER-BOTTOM:black 1pt; BORDER-LEFT:black 1pt\n}\n.prnml4{\nMARGIN-TOP:0em; MARGIN-RIGHT:0em; MARGIN-BOTTOM:0em; MARGIN-LEFT:0.33em !IMPORTANT\n}\n.prnbcc{\nBORDER-COLLAPSE: COLLAPSE; BORDER-TOP:1pt black; BORDER-RIGHT:1pt black; BORDER-BOTTOM:1pt black; BORDER-LEFT:1pt black\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n MISSISSAUGA, ON\n \n \n ,\n \n \n June 22, 2022\n \n \n /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (\"\n \n Cipher\n \n \" or the \"\n \n Company\n \n \") today announced that it held its annual and special meeting of shareholders earlier today and that all matters put forward before shareholders for consideration and approval as set out in the Company's management information circular dated\n \n May 13, 2022\n \n were approved by the requisite majority of votes cast at the meeting. In particular, shareholders approved the election of all director nominees, the re-approval of Ernst & Young LLP as the Company's auditors and approving the unallocated shares, rights and other entitlements under the Company's share purchase plan. A total of 14.2 million shares, representing 55.9% of the total shares outstanding were represented in person or by proxy at the meeting. The Board of Directors (the \"Board\") of the Company is now comprised as follows:\n \n \n \n \n \n \n \n Nominee\n \n \n \n \n \n \n \n \n \n % shares voted for\n \n \n \n \n \n \n % shares withheld\n \n \n \n \n \n \n \n \n Craig Mull\n \n \n \n \n \n \n \n \n \n 91.58\n \n \n \n \n \n \n 8.42\n \n \n \n \n \n \n \n \n Harold Wolkin\n \n \n \n \n \n \n \n \n \n 91.11\n \n \n \n \n \n \n 8.89\n \n \n \n \n \n \n \n \n Christian Godin\n \n \n \n \n \n \n \n \n \n 96.96\n \n \n \n \n \n \n 3.04\n \n \n \n \n \n \n \n \n Arthur Deboeck\n \n \n \n \n \n \n \n \n \n 95.28\...

More updates from Cipher Pharmaceuticals Inc.